Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.31 |
| ▸ | HTR2C | P28335 | 3/20 | 0.31 |
| ▸ | HTR1A | P08908 | 2/20 | 0.31 |
| ▸ | HTR2B | P41595 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15134982 | 0.91 | HTR2A (0.43) | HTR2AHTR2CHTR1AHTR2BCYP1A2 | |
| SCHEMBL15134989 | 0.78 | THRA (0.42) | HTR2BCYP3A4LMNA | |
| SCHEMBL8545516 | 0.76 | — | — | |
| SCHEMBL12758265 | 0.69 | NQO2 (0.32) | LMNA | |
| SCHEMBL481337 | 0.67 | HTR2A (0.54) | HTR2AHTR2CHTR1AHTR2BCYP1A2 | |
| SCHEMBL6703730 | 0.65 | CA1 (0.45) | HTR2AHTR2CHTR2BTSHRLMNA | |
| SCHEMBL8832605 | 0.63 | LMNA (0.38) | HTR2AHTR2CHTR2BTSHRNFKB1 | |
| SCHEMBL9517612 | 0.63 | ALDH1A1 (0.39) | — | |
| SCHEMBL16433700 | 0.62 | — | — | |
| SCHEMBL13318427 | 0.62 | ALDH1A1 (0.43) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121647-B1 | ORGANIC THIN FILM TRANSISTORS COMPRISING THIENYL OLIGOMERS AND THEIR USE AS GASEOUS PHASE SENSORS | UNIV BARI (IT) | 2014-09-24 | — | — | EP | disclosed |
| US-8461354-B2 | Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors | UNIVERSITA' DEGLI STUDI DI BARI (IT) | 2013-06-11 | — | — | US | disclosed |
| US-8461354-B2 | Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors | UNIVERSITA' DEGLI STUDI DI BARI (IT) | 2013-06-11 | — | — | US | disclosed |
| US-20100140597-A1 | Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors | UNIVERSITA' DEGLI STUDI DI BARI (IT) | 2010-06-10 | — | — | US | disclosed |
| US-20100140597-A1 | Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors | UNIVERSITA' DEGLI STUDI DI BARI (IT) | 2010-06-10 | — | — | US | disclosed |
| EP-2121647-A1 | ORGANIC THIN FILM TRANSISTORS COMPRISING THIENYL OLIGOMERS AND THEIR USE AS GASEOUS PHASE SENSORS | Universita' Degli Studi di Bari (IT) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008096239-A1 | ORGANIC THIN FILM TRANSISTORS COMPRISING THIENYL OLIGOMERS AND THEIR USE AS GASEOUS PHASE SENSORS | UNIVERSITA' DEGLI STUDI DI BARI (IT) | 2008-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100140597-A1 | Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors | TPR, TTR, TRPA1 | HTR2A 509/4885HTR2C 1220/4885HTR1A 356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.